The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats

Cancer Biochemistry Biophysics

Volumn 16, Issue 1, 1997, Pages 71-83

  Vasavi, Harikrishnan ^a   Thangaraju, Muthusamy ^a   Babu, Jeganathan Ramesh ^a   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cyclophosphamide, ascorbic acid; Fibrosarcoma; Hyperlipidemia

Indexed keywords

3 METHYLCHOLANTHRENE; ASCORBIC ACID; CYCLOPHOSPHAMIDE; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; FIBROSARCOMA; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; METABOLISM; RAT; SARCOMA; WISTAR RAT;

ANIMALS; ASCORBIC ACID; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CYCLOPHOSPHAMIDE; FATTY ACIDS, NONESTERIFIED; FIBROSARCOMA; HYPERLIPIDEMIAS; LIPID METABOLISM; MALE; METHYLCHOLANTHRENE; NEOPLASM TRANSPLANTATION; PHOSPHOLIPIDS; RATS; RATS, WISTAR; SARCOMA, EXPERIMENTAL; TRIGLYCERIDES;

EID: 0032082769     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bast A , G. R. M. M. Haenen and C. T. A. Doelman (1991). Oxidants and antioxidants - State of the art (Symposium on oxidants and antioxidants). Am. J Med., 91, 2-22.
2. Basu T. K. and D. C. Williams (1975). Plasma and body lipids in patients with carcinoma of the breast. Oncology. 31, 172-176.
3. Bates C. J., A. R. Mandel and T. J. Cole (1977). HDL-cholesterol and vitamin C status. Lancet, 2, 611.
4. Berrigan M. J., R F. Struck and H. L. Gurtoo (1987) Lipid peroxidation induced by cyclophosphamide. Cancer Blochem. Biophys., 9, 265-270.
5. Bonadonna G. and P. Valagussa (1983) Chemotherapy of breast cancer: Current views and results Int. J. Radiat Oncol Biol. Phys., 3, 279-297
6. Burstein M. and H. R. Scholnick (1972). Precipitation of chylomicron and very low density lipoprotein from human serum with sodium lauryl sulphate. Life Sci., 11, 177-84.
7. Bush T. L., L. P. Friend and E. Barrett-Connor (1988). Cholesterol, lipoproteins and coronary heart disease in women. Clin. Chem., 34, 60-70.
8. Calabresi P. and B. A. Chabner (1990). Antineo plastic agents. In, Gilman, A. G., T. W. Rall., A. S. Nies and P. Taylor (Eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, Macmillan, New York. Pp. 1209-1263
9. Clark R. W. and C. C. Crain (1986). Characterization of alterations in plasma lipoprotein lipid and apolipoprotein profiles accompanying hepatoma-induced hyperlipidemia in rats. Cancer Res., 46, 1894-903.
10. Erden F., S. Gulenc, M. Tourn, Z. Kocer, B. Simsek and S. Nebiglu (1985). Ascorbic acid effect on some lipid fractions in human beings. Acta Vitaminol. Enzymol., 7, 131-137.
11. Evans R., L. D. Madison and D. M. Eidlen (1985), Cyclophosphamide-induced changes in the cellular composition of a methylcholanthrene-induced tumor and their relation to bone marrow and blood leukocyte levels. Cancer Res., 40, 395-402.
12. Folsch J., M. Less and G. H. S. Stanley (1975). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509.
13. Frei B., L. England and B. N. Ames (1989). Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA, 86, 6377-6381.
14. Frei B. (1991). Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative damage. Am. J. Clin. Nutr., 54. 1113S-1118S.
15. Ginter E. (1975). Ascorbic acid in cholesterol and bile acid metabolism. Ann. N. Y. Acad. Sci., 258, 410-421.
16. Glomset J. (1972). Blood Lipids and Lipoproteins. In, G. Nelson, (Ed.). Wiley, New York, Pp. 745-787.
17. Hennigar G. R. and P. Gross (1985). Drug and chemical injury-environmental pathology In, J. M. Kissane, (Ed.). Anderson's Pathology. The CV Mosby Company, St. Louis, MO. Pp. 149-238.
18. Horn W. T. and L. A. Menahan (1981). A sensitive method for the determination of free fatty acids in plasma. J. Lipid Res., 22, 377-381.
19. Hanchezhian S., M. Thangaraju, S. Sasirekha and P. Sachdanandam (1995). α-tocopherol ameliorates cyclophosphamide-induced hyper lipidemia in fibrosarcoma bearing rats. Anticancer Drugs, 6, 1-5.
20. Itaya K. (1977). A more sensitive and stable colorimetric determination of free fatty acid in plasma. J. Lipid Res., 18, 663-665.
21. Johnson F. L., T. W. St. Clair, L. L. Rudel (1983). Studies on the production of low density lipoproteins by perfused livers from nonhuman primates. Effects of dietary cholesterol. J Clin. Invest., 72, 221-236.
22. Kotze J. P., M. J. Mathews and W. A. Klerk (1974) Effect of ascorbic acid on lipoprotein lipase activity. S. Afr. Med. J., 48, 511-514.
23. Krasner N. and I. W. Dymock (1974). Ascorbic acid deficiency in malignant diseases: a clinical and biochemical study. Br. J. Cancer, 30, 142-145.
24. Kumar K., R. Arivazhagan and P. Sachdanandam (1991). Studies on changes in the levels of a few lipid metabolising enzymes in breast cancer patients. Med. Sci. Res., 19, 305-306.
25. Leffler H. H. and C. H. McDougald (1963). A colorimetric method for the estimation of cholesterol. Am. J. Clin. Pathol., 39, 311-313.
26. Lespine A., C. Azema, M. Gavels, J. Manent, N. Dousset, H. Chap and B. Perret (1993). Lipoprotein lipase regulation in cyclophosphamide treated rabbits-dependence on nutritional status. J Lipid Res., 34, 23-36.
27. Loudet A. M., N. Dousset, M. Carton and L. Douste-Blazy (1984). Effects of an antimitotic agent cyclophosphamide on post-heparin plasma lipoproteins lipase activity in rabbits. Biochem. Pharmacol., 33, 2961-2965.
28. Lyon I., R. Kannan, M. Ookhtens and N. Baker (1982). Turnover and transport of plasma very low density lipoprotein triglycerides in mice bearing Ehrlich ascites carcinoma. Cancer Res., 42, 132-138.
29. Mathur I. S., N. B. Singh, H. P. Gupta and S. K. Gupta (1979). Effect of cyclophosphamide and mitomycin C on Walker Carcinoma 256 grown in liver and muscle. Ind. J. Med. Res., 69, 284-289.
30. Mohana K and K. K. Purushothaman (1980), A study of its anticancer, antibacterial and antifungal properties, Ind. J. Exp. Biol., 18, 876-877.
31. Nomura A., B. E. Henderson and J. Lee (1978). Breast cancer and diet among the Japanese in Hawaii. Am. J. Clin. Nutr., 31, 2020-2029.
32. Parekh A. C. and D. H. Jung (1970). Cholesterol determination with ferric chloride-uranyl acetate and sulphuric acid-ferrous sulphate reagents. Anal. Chem., 42, 1423-1427.
33. Patel J. M. (1990). Metabolism and Pulmonary toxicity in cyclophosphamide. Pharmacol. Ther., 47, 137-146.
34. Pauling L. (1979). Role of Vitamin C in Cancer. In, A. Hanck and R. Ritzel (Eds.). Hans Hube Publ, Bern. Pp. 207-210.
35. Premalatha B , M. Thangaraju and P. Sachdanandam (1995). Influence of cyclophosphamide and vitamin E administration on the rate of lipid peroxidation in experimental fibrosarcoma in rats. J. Clin. Biochem. Nutr., 18, 79-87.
36. Rice E. W. (1970). Triglycerides in serum. In, P. Roderick and C. H. MacDonald (Eds.). Standard Methods in Clinical Chemistry, 6th ed. Academic Press, New York. Pp. 215-222.
37. Rouser G., S. Fleisher and A. Yamanoro (1970). Two dimensional thin layer Chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids, 5, 494-496.
38. Surendra G., R. Savitha, A. Chandana and A. H. Kapadi (1992). Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay. Teratog. Carcinog. Mutagen., 12, 11-17.
39. Swift L. L., N. R. Mahowitz, G. D. Don and V. S. Le Quire (1979). Cholesterol and saturated fat diet induces hepatic synthesis of cholesterol rich lipoproteins. Clin. Res., 27, 378A.
40. Theriault R. L., G. N. Hortobagyi, S. W. Kau, F. A. Holmes, V. Hug, G. Fraschini, K. Jabboury and A. U. Buzhar (1988). Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin and cyclophosphamide in the treatment of metastatic breast cancer. Cancer, 62, 2105-2110.
41. Touster O. and S. Hollman (1961). Nutritional and enzymatic studies on the mechanism of stimulation of ascorbic acid synthesis by drugs and carcinogenic hydrocarbons. Ann. N. Y., Acad. Sci., 91, 318-323.
42. Van Handle E. (1961). Modification of the microdetermining triglycerides. Clin. Chem., 7, 249-251.
43. Vasavi H., M. Thangaraju and P. Sachdanandam (1994). Effect of α-tocopherol on lipid peroxidation and antioxidant system in fibrosarcoma bearing rats. Mol. Cell. Biochem., 131, 125-129.
44. Watkins T., P. Lenz, A. Gapor, M. Struck, A. Tomco and M. Biesenbaum (1993). δ-Tocotrienol as a hypocholesterolenic and antioxidant agent in rats fed atherogenic diets. Lipids, 28, 1113-1118.
45. Wilson D. E and M. J. Spiger (1973). A dual precipitation method for quantitative lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med., 82, 473-483.
46. Windier E., P. T. Kovanan, Y. S. Chao, M. S. Brown, R. J. Havel and J. L Goldstein (1980). The estradiol stimulated lipoprotein receptor of rat liver: a binding site that mediates uptake of rat lipoproteins containing apoproteins B and E J. Biol. Chem., 255, 10464-10471.
47. Wood C B , N. A. Habib and A. Thomson (1985). Increase of oleic acid in erthrocytes associated with malignancies. Br. Med. J., 291, 163-165